NASDAQ:JAGX - Jaguar Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.33 0.00 (0.00 %)
(As of 03/22/2019 09:13 AM ET)
Previous Close$0.3237
Today's Range$0.25 - $0.34
52-Week Range$0.12 - $3.53
Volume20.49 million shs
Average Volume8.16 million shs
Market Capitalization$21.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07
Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its human health product pipelines include Mytesi, which is Phase II clinical trial for the treatment of cancer therapy-related diarrhea, as well as for the supportive care for inflammatory bowel disease; formulation of crofelemer that is Phase II clinical trial for the treatment of short bowel syndrome, congenital diarrheal disorders, and irritable bowel syndrome - diarrhea predominant diseases; and SB-300, a second-generation anti-secretory agent for multiple indications, including cholera. The company's animal health product candidates comprise Canalevia, an animal prescription drug product candidate intended for treatment of various forms of diarrhea in dogs; and Equilevia is Jaguar's non-prescription product for total gut health in equine athletes. In addition, the company's products include Neonorm Calf and Neonorm Foal. Jaguar Health, Inc. is headquartered in San Francisco, California.

Receive JAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JAGX
CUSIPN/A
Phone415-371-8300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.36 million
Book Value$2.46 per share

Profitability

Net Income$-21,960,000.00
Net Margins-908.28%

Miscellaneous

EmployeesN/A
Market Cap$21.12 million
Next Earnings Date3/25/2019 (Estimated)
OptionableNot Optionable

Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

How were Jaguar Health's earnings last quarter?

Jaguar Health Inc (NASDAQ:JAGX) issued its earnings results on Monday, November, 14th. The biotechnology company reported ($0.30) EPS for the quarter, beating the Zacks' consensus estimate of ($0.40) by $0.10. The biotechnology company earned $0.05 million during the quarter, compared to the consensus estimate of $0.10 million. Jaguar Health had a negative return on equity of 259.67% and a negative net margin of 908.28%. View Jaguar Health's Earnings History.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release their next quarterly earnings announcement on Monday, March 25th 2019. View Earnings Estimates for Jaguar Health.

Has Jaguar Health been receiving favorable news coverage?

Headlines about JAGX stock have trended neutral recently, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Jaguar Health earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave media stories about the biotechnology company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the immediate future.

Who are some of Jaguar Health's key competitors?

What other stocks do shareholders of Jaguar Health own?

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the folowing people:
  • Ms. Lisa A. Conte, Founder, CEO, Pres & Director (Age 60)
  • Ms. Karen S. Wright, CFO & Treasurer (Age 63)
  • Dr. Steven R. King, Exec. VP of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec. (Age 61)
  • Dr. Pravin R. Chaturvedi, Chair of Scientific Advisory Board & Acting Chief Scientific Officer (Age 56)
  • Mr. Jonathan S. Wolin, Chief Compliance Officer & Corp. Counsel

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at $7.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $0.3254.

How big of a company is Jaguar Health?

Jaguar Health has a market capitalization of $21.12 million and generates $4.36 million in revenue each year.

What is Jaguar Health's official website?

The official website for Jaguar Health is http://www.jaguaranimalhealth.com.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at 415-371-8300.


MarketBeat Community Rating for Jaguar Health (NASDAQ JAGX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  213 (Vote Outperform)
Underperform Votes:  171 (Vote Underperform)
Total Votes:  384
MarketBeat's community ratings are surveys of what our community members think about Jaguar Health and other stocks. Vote "Outperform" if you believe JAGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JAGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel